Sobi Eyes Japan Approval of 4 Rare Disease Drugs in 5 Years: Local Chief

Sobi Japan President Toshiya Nakagawa Rare disease specialist Swedish Orphan Biovitrum Japan (Sobi Japan) aims to score Japanese regulatory approval for four drugs within the next five years, planning to launch an in-house sales team at least for some of...read more